1. Home
  2. KFY vs CORT Comparison

KFY vs CORT Comparison

Compare KFY & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Korn Ferry

KFY

Korn Ferry

HOLD

Current Price

$60.49

Market Cap

3.4B

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$38.49

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KFY
CORT
Founded
1969
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.7B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
KFY
CORT
Price
$60.49
$38.49
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$78.00
$114.20
AVG Volume (30 Days)
459.8K
2.0M
Earning Date
03-10-2026
02-18-2026
Dividend Yield
3.08%
N/A
EPS Growth
5.12
N/A
EPS
4.91
0.87
Revenue
$2,811,089,000.00
$741,172,000.00
Revenue This Year
$5.60
$23.09
Revenue Next Year
$4.16
$29.62
P/E Ratio
$12.71
$46.75
Revenue Growth
3.78
17.92
52 Week Low
$59.23
$32.99
52 Week High
$78.50
$117.33

Technical Indicators

Market Signals
Indicator
KFY
CORT
Relative Strength Index (RSI) 32.64 36.31
Support Level $66.53 $38.10
Resistance Level $68.31 $41.92
Average True Range (ATR) 2.25 2.14
MACD -0.71 1.03
Stochastic Oscillator 3.66 16.96

Price Performance

Historical Comparison
KFY
CORT

About KFY Korn Ferry

Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: